We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity.
- Authors
Ricchi, Paolo; Costantini, Silvia; Spasiano, Anna; Cinque, Patrizia; Esposito, Simona; Filosa, Aldo
- Abstract
In fact, both transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT) patients have well-recognized risk factor for developing HCC. Dear Editor, Hepatocellular carcinoma (HCC) is an emerging and growing entity among patients with thalassemia. Until December 2020, we detected eight cases of HCC: five cases in TDT (three males, two female), two cases in NTDT (one male, one female), and one case in a female patient who had undergone hematopoietic stem cells transplantation (HSCT) in 1997 (HCC cumulative incidence 3.36%).
- Subjects
HEPATOCELLULAR carcinoma; HEPATITIS C; THALASSEMIA; HEMATOPOIETIC stem cell transplantation; MAGNETIC resonance imaging
- Publication
Annals of Hematology, 2021, Vol 100, Issue 7, p1907
- ISSN
0939-5555
- Publication type
letter
- DOI
10.1007/s00277-021-04511-1